Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical developments for treating ARDS.

Stephanie Eaton1, Greg Martin

  • 1Division of Pulmonary and Critical Care Medicine, Emory University, 550 Peachtree Street NE, Atlanta, GA 30308, USA. seaton2@emory.edu

Expert Opinion on Investigational Drugs
|January 5, 2002
PubMed
Summary

Acute respiratory distress syndrome (ARDS) involves lung inflammation and fluid buildup. While some treatments improve oxygen levels, mortality benefits are limited, necessitating further research into effective therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Chalcone Synthase-like Bacterial Protein Catalyzes Heterocyclic C-Ring Cleavage of Naringenin to Alter Bioactivity Against Nuclear Receptors in Colonic Epithelial Cells.

Metabolites·2025
Same author

Human respiratory syncytial virus genetic diversity and lineage replacement in Ireland pre- and post-COVID-19 pandemic.

Microbial genomics·2025
Same author

The Shift to Over-the-Counter Diagnostic Testing After RADx: Clinical, Regulatory, and Societal Implications.

IEEE open journal of engineering in medicine and biology·2025
Same author

National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned.

Annals of internal medicine·2024
Same author

Resources to facilitate patient engagement in research.

BMJ (Clinical research ed.)·2024
Same author

Increased Incidence of Vestibular Disorders in Patients With SARS-CoV-2.

Otology & neurotology open·2024

Area of Science:

  • Pulmonology
  • Critical Care Medicine
  • Pathophysiology

Background:

  • Acute respiratory distress syndrome (ARDS) is a severe lung condition characterized by capillary permeability and pulmonary edema.
  • It presents clinically with radiographic infiltrates, severe hypoxemia, and reduced lung compliance, complicating various medical and surgical conditions.
  • ARDS represents a self-perpetuating inflammatory state with complex pathophysiology.

Purpose of the Study:

  • To review the current understanding of ARDS pathophysiology.
  • To evaluate the efficacy of various investigational therapies targeting specific pathophysiological pathways.
  • To discuss the role of supportive care in managing ARDS.

Main Methods:

  • Review of existing research on ARDS pathophysiology and therapeutic interventions.

Related Experiment Videos

  • Analysis of clinical trial data for therapies including nitric oxide, surfactant replacement, and mediator-targeted agents.
  • Evaluation of supportive care strategies such as mechanical ventilation, fluid balance, and nutrition.

    • Main Results:

    • Nitric oxide (NO) improves oxygenation in most ARDS patients but does not reduce mortality.
    • Surfactant replacement has shown limited success in adults, though new approaches may be beneficial.
    • Neutrophil elastase inhibitors show promise and are in Phase III trials, while other mediator-targeted therapies have largely failed in large trials.

    Conclusions:

    • Despite progress, effective mortality-reducing therapies for ARDS remain elusive.
    • Targeted therapies, including neutrophil elastase inhibitors, continue to be investigated.
    • Supportive care, particularly mechanical ventilation, fluid management, and nutrition, remains crucial while specific treatments are developed.